Cori Gorman
Chief Executive Officer at BioXpress Therapeutics SA
Cori Gorman active positions
| Companies | Position | Start | End |
|---|---|---|---|
BioXpress Therapeutics SA
 BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Chief Executive Officer | 2010-06-30 | - |
| Chairman | 2010-06-30 | - |
Career history of Cori Gorman
Former positions of Cori Gorman
| Companies | Position | Start | End |
|---|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Corporate Officer/Principal | - | - |
Statistics
International
| Switzerland | 3 |
Operational
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoral
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Cori Gorman
- Experience
